Change in quality of life measures from baseline to end of follow-up by comorbidity count.</p
Change in categorized severity levels of anxiety and depression between baseline and mean follow-up....
The trend of bilirubin levels of all, intervention, and control groups from baseline to discharge.</...
<p>Baseline demographic status and comorbidity between statin users and non-users.</p
<p>Change in the health-related quality of life from baseline to12-month follow-up between groups.</...
Variation in the effect of treatment on quality of life by comorbidity count.</p
Quality of life measured by the SF-36, change from baseline scores five years after lifestyle interv...
Change in outcome measures from baseline to post-intervention by treatment groups.</p
<p>Quality of life and psychiatric comorbidities (FDDQL and PHQ-D) during the course of the study.</...
<p>The number changes of patients in each score of RVDD at baseline and last follow-up.</p
The association of comorbidity and change in quality of life measures with treatment interaction (or...
<p>The number changes of patients in each score of LVDD at baseline and last follow-up.</p
Changes from the baseline values in other diabetes-related variables at the end of the treatment per...
<p>BMI change between baseline and follow-up, overall and according to health perception at baseline...
Descriptive statistics and baselines changes in life satisfaction by group (N = 8,661).</p
<p>Changes in maternal and newborn health indicators between baseline and follow-up surveys.</p
Change in categorized severity levels of anxiety and depression between baseline and mean follow-up....
The trend of bilirubin levels of all, intervention, and control groups from baseline to discharge.</...
<p>Baseline demographic status and comorbidity between statin users and non-users.</p
<p>Change in the health-related quality of life from baseline to12-month follow-up between groups.</...
Variation in the effect of treatment on quality of life by comorbidity count.</p
Quality of life measured by the SF-36, change from baseline scores five years after lifestyle interv...
Change in outcome measures from baseline to post-intervention by treatment groups.</p
<p>Quality of life and psychiatric comorbidities (FDDQL and PHQ-D) during the course of the study.</...
<p>The number changes of patients in each score of RVDD at baseline and last follow-up.</p
The association of comorbidity and change in quality of life measures with treatment interaction (or...
<p>The number changes of patients in each score of LVDD at baseline and last follow-up.</p
Changes from the baseline values in other diabetes-related variables at the end of the treatment per...
<p>BMI change between baseline and follow-up, overall and according to health perception at baseline...
Descriptive statistics and baselines changes in life satisfaction by group (N = 8,661).</p
<p>Changes in maternal and newborn health indicators between baseline and follow-up surveys.</p
Change in categorized severity levels of anxiety and depression between baseline and mean follow-up....
The trend of bilirubin levels of all, intervention, and control groups from baseline to discharge.</...
<p>Baseline demographic status and comorbidity between statin users and non-users.</p